Ledger.Open graph →
SEC Form D · filed September 5, 2018

PTC THERAPEUTICS, INC

Offering
$150.0M
Sold
$150.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH PLAINFIELD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Patrick J. Morris · Chicago, ILDirectorKristy Gannon · Menlo Park, CAExecFintan Kelly · Menlo Park, CADirectorDallas M. Hakes · Springville, UTDirectorDarien S. Parhad · Chicago, ILDirectorTimothy Streufert · Los Angeles, CADirectorPaul Norman · Irvine, CAExecJoseph Malhas · Los Angeles, CAExec · DirectorHoward Leonhardt · Irvine, CADirectorRama J. Ranganathan · Chicago, ILExecAnna C. Castner Wightman · CENTENNIAL, CODirectorFernanda A. Fenga · CENTENNIAL, COExecAlan Kelley · Silver Spring, MDDirectorJohn Spegal · Teaneck, NJDirectorStuart Mcleod · San Francisco, CAExecJohn Freeman · San Francisco, CADirectorJoe Onofrio · San Francisco, CADirectorLuke Murray · VICTORIA, Channel IslandsExec · DirectorNicholas Crocker · VICTORIA, Channel IslandsDirectorAlexander Birch · VICTORIA, Channel IslandsExecMarcio S. Souza · South Plainfield, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗